Clinical Trials Logo

Stroke, Acute clinical trials

View clinical trials related to Stroke, Acute.

Filter by:

NCT ID: NCT04105322 Not yet recruiting - Stroke, Acute Clinical Trials

Effects of Kinesio Taping on Balance and Functional Performance in Stroke Patients

Start date: September 2019
Phase: N/A
Study type: Interventional

This study is planned to investigate the acute effects of trunk kinesio taping on balance and functional performance in acute stroke patients.

NCT ID: NCT04105257 Completed - Stroke, Acute Clinical Trials

Evaluation of Diagnostic Performance of Cerebral Perfusion Scans in Pseudo-Stroke

CTP
Start date: October 20, 2019
Phase: N/A
Study type: Interventional

When a patient is received with the context of acute stroke, they undergo a fast neurological evaluation and obtain a basic appraisal composed of a non-contrast endovascular cerebral scan and an angiography scan of intracranial blood vessels and the neck. Once the structural lesion (hemorrhage, tumor, etc.) is absent, signs of early infracts and confirmed acute intracranial arterial occlusion, the possibility of a pseudo-stroke dwells in the differential diagnostic. Certain characteristics of history and clinical evaluation create sufficient doubt to evoke the possibility of a pseudo-stroke. In fact, this population is mostly female and the cardiovascular risk factors are less prevalent in this group than for the group of stroke victims. It is on average the youngest and presents a less severe deficit. For the rest, medical antecedents often help to evoke a diagnosis of pseudo-stroke.

NCT ID: NCT04102956 Completed - Stroke, Acute Clinical Trials

Human Urinary Kallidinogenase Improve Short Term Motor Functional Outcome of Acute Ischemia Stroke Patients

Start date: July 1, 2017
Phase: Phase 4
Study type: Interventional

Acute cerebral infarction is a common type of ischemic stroke, causing brain dysfunction in patients with high morbidity and disability. With the changes in people's diet, lifestyle patterns and population aging, the incidence of acute cerebral infarction has increased year by year, which has become an important cause of disability and death in middle-aged and elderly patients. The human urinary kallidinogenase (HUK) was used in China in the management of acute ischemic stroke (AIS) in recent years. However, the mechanism of HUK on AIS has not been systematically investigated. This study aimed to assess the effect of HUK on motor functional outcome and relative corticospinal tract recovery in the patients with AIS. Diffusion tensor imaging(DTI) and diffusion tensor tractography(DTT) have all been used to observe features of cerebral white matter fibrous structures. In addition, diffusion tensor tractography which is used to trace fiber bundle and evaluate white matter fiber bundle integrity and direction is the only non-invasive imaging method to display the corticospinal tract in vivo.

NCT ID: NCT04092543 Recruiting - Stroke, Acute Clinical Trials

Validation of DRAGON Versus a Simplified DRAGON/Machine Learning

Start date: March 1, 2019
Phase:
Study type: Observational

The CT-DRAGON score can predict long-term functional outcome after acute stroke treated by thrombolysis. However, implementation in clinical practice is hampered by a lack of validation in the broad spectrum of stroke patients undergoing thrombectomy, whether or not in combination with thrombolysis or conservative treatment. Furthermore, the CT-DRAGON score considers multiple items, which are not always readily available in every setting. This study aims to investigate whether either a simplified version of the CT-DRAGON score with only three clinical items or a machine learning technique could be as powerful and more feasible.

NCT ID: NCT04088578 Completed - Stroke, Acute Clinical Trials

VNS-supplemented Motor Retraining After Stroke

Start date: September 22, 2019
Phase: N/A
Study type: Interventional

The goal of this study is to learn more about the connections between the brain, spinal cord, and muscles and how these connections can be strengthened after neurological injury.

NCT ID: NCT04083001 Active, not recruiting - Stroke, Acute Clinical Trials

An Open, Study to Assess the Safety of RGTA® (OTR4132) in Patients With Acute Ischemic Stroke (AIS)

MATRISS
Start date: March 3, 2022
Phase: N/A
Study type: Interventional

RGTA® (ReGeneraTing Agent) are synthetic polysaccharides mimicking extra-cellular matrix scaffold elements and protective agents called Heparan Sulphates (HSPGs). OTR4132-MD is provided as a sterile injectable medical device. OTR4132-MD is indicated in anterior circulation acute ischemic stroke (AIS) patients re-vascularized (TICI score 2b - 3) by combined thrombolysis and endovascular thrombectomy within 6 hours of symptoms onset.

NCT ID: NCT04080817 Not yet recruiting - Stroke, Acute Clinical Trials

Neolexon® Aphasia-App in Acute Aphasia After Stroke

Lexi
Start date: October 1, 2019
Phase: N/A
Study type: Interventional

Up to now there is proven evidence of traditional logopedic therapy in aphasia, but recent computer-based algorithms also showed their evidence so far. Due to small and heterogenous study populations further trials are urgently needed. This prospective, randomized, clinical & experimental controlled noninvasive study is intended to provide data for the therapy of an individual approach in aphasia patients.

NCT ID: NCT04062643 Completed - Stroke, Acute Clinical Trials

Obesity Effect on Stroke and Cardiovascular Events

OSR
Start date: April 2000
Phase:
Study type: Observational

The relation between obesity and stroke recurrence is still under debate. In this study it has been sought whether baseline obesity is associated with recurrent stroke and major cardiovascular events in a long-time period.

NCT ID: NCT04057690 Recruiting - Stroke, Acute Clinical Trials

Automatic PredICtion of Edema After Stroke

APICES
Start date: April 1, 2019
Phase:
Study type: Observational

To use machine learning for early detection of malignant brain edema in patients with MCA ischemia

NCT ID: NCT04048668 Suspended - Stroke, Acute Clinical Trials

tDCS to Treat Subacute Aphasia

Start date: September 1, 2019
Phase: N/A
Study type: Interventional

This study proposes to use transcranial direct current stimulation (tDCS), a technique by which a very small electrical current (2 mA) is applied to the scalp, along side speech therapy in patients with subacute stroke and aphasia in order to enhance language recovery. Aphasic patients in an inpatient neurorehabilitation facility who have experienced a stroke between one week and three months prior to enrollment will be invited to participate. Participants will receive either real or sham tDCS to the left hemisphere of the brain for a minimum of 5 consecutive sessions to up-to a max of 10 sessions depending on the length of their rehab stay . Stimulation will be paired with with the patient's normal speech therapy schedule. Participant's language skills will be assessed at baseline and immediately after the last session of therapy in order to determine whether tDCS is associated with either transient or persistent improvement in language.